Table 2. Preventive potential of current HPV vaccines in Stockholm County, LSIL and ASCUS.
|
Diagnostic group
|
||||
|---|---|---|---|---|
| All | ASCUS | LSIL | ||
| HPV types | No. (%) (n=343) | No. (%) (n=120) | No. (%) (n=223) | P |
| HPV+ (any type) | 282 (82) | 75 (63) | 207 (93) | <0.001 |
| HR-HPV+ | 217 (63) | 59 (49) | 158 (70) | <0.001 |
| HPV16+ | 65 (19) | 19 (16) | 46 (21) | 0.28 |
| HPV18+ | 28 (8) | 8 (7) | 20 (9) | 0.46 |
| HPV16/18+ | 89 (26) | 26 (22) | 63 (28) | 0.18 |
| Clade 9+ | 154 (45) | 44 (37) | 110 (49) | 0.02 |
| Clade 7+ | 108 (31) | 31 (26) | 77 (35) | 0.10 |
| Clade 7/9+ | 206 (60) | 58 (48) | 148 (66) | 0.001 |
ASCUS=atypical squamous cells of undetermined significance; HPV=human papillomavirus; LSIL=low-grade squamous intraepithelial lesion.
P-values indicate differences between ASCUS and LSIL cases.
Clade 7: HPV18, 39, 45, 59, 68, 70.
Clade 9: HPV16, 31, 33, 35, 52, 58, 67.